Your browser doesn't support javascript.
loading
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia.
Villafuerte, David; Aliberti, Stefano; Soni, Nilam J; Faverio, Paola; Marcos, Pedro J; Wunderink, Richard G; Rodriguez, Alejandro; Sibila, Oriol; Sanz, Francisco; Martin-Loeches, Ignacio; Menzella, Francesco; Reyes, Luis F; Jankovic, Mateja; Spielmanns, Marc; Restrepo, Marcos I.
Afiliação
  • Villafuerte D; Division of Pulmonary Diseases and Critical Care Medicine, University of Texas Health - San Antonio, San Antonio, TX, USA.
  • Aliberti S; Division of Pulmonary Diseases and Critical Care Medicine, South Texas Veterans Health Care System, San Antonio, TX, USA.
  • Soni NJ; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Respiratory Unit and Cystic Fibrosis Adult Center, Milan, Italy.
  • Faverio P; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • Marcos PJ; Division of Pulmonary Diseases and Critical Care Medicine, University of Texas Health - San Antonio, San Antonio, TX, USA.
  • Wunderink RG; Division of Pulmonary Diseases and Critical Care Medicine, South Texas Veterans Health Care System, San Antonio, TX, USA.
  • Rodriguez A; Cardio-Thoracic-Vascular Department, University of Milan Bicocca, Respiratory Unit, San Gerardo Hospital, ASST di Monza, Monza, Italy.
  • Sibila O; Servicio de Neumología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complejo Hospitalario Universitario de A Coruña (CHUAC) Sergas Universidade da Coruña (UDC), A Coruña, Spain.
  • Sanz F; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Martin-Loeches I; Hospital Universitari Joan XXIII, Critical Care Medicine, Rovira and Virgili University and CIBERes (Biomedical Research Network of Respiratory Disease), Tarragona, Spain.
  • Menzella F; Servei de Pneumologia, Departamento de Medicina, Hospital Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Reyes LF; Pulmonology Department, Consorci Hospital General Universitari de Valencia, Valencia, Spain.
  • Jankovic M; St. James's Hospital, Trinity Centre for Health Sciences, CIBERES, Dublin, Ireland.
  • Spielmanns M; Department of Cardiac-Thoracic-Vascular and Intensive Care Medicine, Pneumology Unit, IRCCS - Arcispedale Santa Maria Nuova, Reggio Emilia, Italy.
  • Restrepo MI; Department of Microbiology, Universidad de la Sabana, Bogota, Colombia.
Respirology ; 25(5): 543-551, 2020 05.
Article em En | MEDLINE | ID: mdl-31385399
ABSTRACT
BACKGROUND AND

OBJECTIVE:

Enterobacteriaceae (EB) spp. family is known to include potentially multidrug-resistant (MDR) microorganisms, and remains as an important cause of community-acquired pneumonia (CAP) associated with high mortality. The aim of this study was to determine the prevalence and specific risk factors associated with EB and MDR-EB in a cohort of hospitalized adults with CAP.

METHODS:

We performed a multinational, point-prevalence study of adult patients hospitalized with CAP. MDR-EB was defined when ≥3 antimicrobial classes were identified as non-susceptible. Risk factors assessment was also performed for patients with EB and MDR-EB infection.

RESULTS:

Of the 3193 patients enrolled with CAP, 197 (6%) had a positive culture with EB. Fifty-one percent (n = 100) of EB were resistant to at least one antibiotic and 19% (n = 38) had MDR-EB. The most commonly EB identified were Klebsiella pneumoniae (n = 111, 56%) and Escherichia coli (n = 56, 28%). The risk factors that were independently associated with EB CAP were male gender, severe CAP, underweight (body mass index (BMI) < 18.5) and prior extended-spectrum beta-lactamase (ESBL) infection. Additionally, prior ESBL infection, being underweight, cardiovascular diseases and hospitalization in the last 12 months were independently associated with MDR-EB CAP.

CONCLUSION:

This study of adults hospitalized with CAP found a prevalence of EB of 6% and MDR-EB of 1.2%, respectively. The presence of specific risk factors, such as prior ESBL infection and being underweight, should raise the clinical suspicion for EB and MDR-EB in patients hospitalized with CAP.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Comunitárias Adquiridas / Enterobacteriaceae / Infecções por Enterobacteriaceae / Hospitalização Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Comunitárias Adquiridas / Enterobacteriaceae / Infecções por Enterobacteriaceae / Hospitalização Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article